Author: Andrew Horowitz

The Disciplined Investor Podcast – Episode 9

Larry Kudlow interview, Preferred Stocks for tax advantaged income, Merger and Buyout candidates, Real Estate concerns. This show is jam packed!

Larry Kudlow of Kudlow and Company, CNBC nightly. We ask: What is going on with the markets, is Asia a concern and is the dollar undervalued.Who is likely to...

Read More

DNDN – More Info and More Confusion on Provenge

The saga continues with DNDN. The stock is moving a bit higher. There are many people’s lives that may now be in further disarray as the long-awaited and deeply hoped-for FDA approval of the prostrate cancer treatment Provenge has been delayed. There is a rather large commotion concerning several inconsistencies...

Read More

CNBC Portfolio Challenge Final Results – 2007

We ended with a $375,000 profit!

The 10 week contest is over and we came out in the top one percent of all portfolios. The fact is that we were as high as 900 and dropped down only during the final 2 weeks while still remaining in the top...

Read More

Dendreon – Is Provenge Snake Oil or Cure?

Dendreon Corporation (DNDN) took a huge fall the past few days after the FDA released an update to their “Approvable Letter”, asking for additional information regarding the efficacy of Provenge. This drug is, as most would say; “potentially revolutionary because it aims to teach the body’s own immune system to...

Read More

The Disciplined Investor Podcast – Episode 8

ARE WE CRAZY? What is going on in these markets… Time to protect portfolio…Markets are out of whack and we need to look at why that is.

The fact is that the extreme volatility we are seeing individual positions is reason to take a step back and look at what is...

Read More